Cargando…

Sexual dysfunction in chemsex users - research report

INTRODUCTION: Epidemiology and etiology of sexual disorders and problems have been described in detail for heterosexual men. In the case of MSM, scientific studies are much more limited, and the presented frequencies depend largely on the methodology of the study and the population covered by the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalczyk, R. M., Stola, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478944/
http://dx.doi.org/10.1192/j.eurpsy.2023.2336
_version_ 1785101459267780608
author Kowalczyk, R. M.
Stola, A.
author_facet Kowalczyk, R. M.
Stola, A.
author_sort Kowalczyk, R. M.
collection PubMed
description INTRODUCTION: Epidemiology and etiology of sexual disorders and problems have been described in detail for heterosexual men. In the case of MSM, scientific studies are much more limited, and the presented frequencies depend largely on the methodology of the study and the population covered by the study (socio-cultural differences, influence of minority stress). For chemsex users, the data is even more enigmatic; the subchapter presents data from the research currently conducted in Poland that has not yet been published.Most studies in the recent past have focused on assessing the risk of HIV transmission, sexual dysfunction associated with diagnosis, and the use of antiretroviral drugs. Only recently have been published papers, though still few, assessing the frequency of specific sexual dysfunctions among MSM, which are included as a whole group. It should be emphasized that there is currently no conclusive evidence to suggest a different diagnostic or therapeutic approach for sexual dysfunction in MSM patients. OBJECTIVES: Most studies in the recent past have focused on assessing the risk of HIV transmission, sexual dysfunction associated with diagnosis, and the use of antiretroviral drugs. Only recently have been published papers, though still few, assessing the frequency of specific sexual dysfunctions among MSM, which are included as a whole group. It should be emphasized that there is currently no conclusive evidence to suggest a different diagnostic or therapeutic approach for sexual dysfunction in MSM patients. The aim of the presented report is to supplement the knowledge about the MSM population of Chemsex users. METHODS: A focus group of 60 men aged 18-50 split was assembledinto four groups depending on the type of sexual contact (ChemSex non-ChemSex) and HIV +/-. The focus data was supplemented with research tools: a questionnaire containing 75 questions - elements of medical and sexological interview, and a standardized scale: The quality of life questionnaire in relation to sex - Male (Polish version of the SQoL-M), Premature ejaculation questionnaire and the International Index of Erectile Function (IIEF). RESULTS: The results are being analyzed. The full report will be presented at the conference. CONCLUSIONS: The aim of the project is to assess the quality of sexual life and to examine the frequency of sexual dysfunction in the MSM population, active Chemsex users and the frequency of sexual contacts, the number of sexual partners, perceived sexual needs and satisfaction, as well as to determine the psychosocial / medical factors influencing the occurrence of sexual dysfunction. Supplementing knowledge in this field will allow for more effective therapeutic effects. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10478944
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104789442023-09-06 Sexual dysfunction in chemsex users - research report Kowalczyk, R. M. Stola, A. Eur Psychiatry Abstract INTRODUCTION: Epidemiology and etiology of sexual disorders and problems have been described in detail for heterosexual men. In the case of MSM, scientific studies are much more limited, and the presented frequencies depend largely on the methodology of the study and the population covered by the study (socio-cultural differences, influence of minority stress). For chemsex users, the data is even more enigmatic; the subchapter presents data from the research currently conducted in Poland that has not yet been published.Most studies in the recent past have focused on assessing the risk of HIV transmission, sexual dysfunction associated with diagnosis, and the use of antiretroviral drugs. Only recently have been published papers, though still few, assessing the frequency of specific sexual dysfunctions among MSM, which are included as a whole group. It should be emphasized that there is currently no conclusive evidence to suggest a different diagnostic or therapeutic approach for sexual dysfunction in MSM patients. OBJECTIVES: Most studies in the recent past have focused on assessing the risk of HIV transmission, sexual dysfunction associated with diagnosis, and the use of antiretroviral drugs. Only recently have been published papers, though still few, assessing the frequency of specific sexual dysfunctions among MSM, which are included as a whole group. It should be emphasized that there is currently no conclusive evidence to suggest a different diagnostic or therapeutic approach for sexual dysfunction in MSM patients. The aim of the presented report is to supplement the knowledge about the MSM population of Chemsex users. METHODS: A focus group of 60 men aged 18-50 split was assembledinto four groups depending on the type of sexual contact (ChemSex non-ChemSex) and HIV +/-. The focus data was supplemented with research tools: a questionnaire containing 75 questions - elements of medical and sexological interview, and a standardized scale: The quality of life questionnaire in relation to sex - Male (Polish version of the SQoL-M), Premature ejaculation questionnaire and the International Index of Erectile Function (IIEF). RESULTS: The results are being analyzed. The full report will be presented at the conference. CONCLUSIONS: The aim of the project is to assess the quality of sexual life and to examine the frequency of sexual dysfunction in the MSM population, active Chemsex users and the frequency of sexual contacts, the number of sexual partners, perceived sexual needs and satisfaction, as well as to determine the psychosocial / medical factors influencing the occurrence of sexual dysfunction. Supplementing knowledge in this field will allow for more effective therapeutic effects. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10478944/ http://dx.doi.org/10.1192/j.eurpsy.2023.2336 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Kowalczyk, R. M.
Stola, A.
Sexual dysfunction in chemsex users - research report
title Sexual dysfunction in chemsex users - research report
title_full Sexual dysfunction in chemsex users - research report
title_fullStr Sexual dysfunction in chemsex users - research report
title_full_unstemmed Sexual dysfunction in chemsex users - research report
title_short Sexual dysfunction in chemsex users - research report
title_sort sexual dysfunction in chemsex users - research report
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478944/
http://dx.doi.org/10.1192/j.eurpsy.2023.2336
work_keys_str_mv AT kowalczykrm sexualdysfunctioninchemsexusersresearchreport
AT stolaa sexualdysfunctioninchemsexusersresearchreport